pharma · Non Small Cell Lung Cancer · Locally Advanced Solid Tumor · TNGX
Tango Therapeutics
News and analysis for Tango Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Boston, USA HQ
2017 Founded
154 Employees
Public company Type
TNGX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2017
- Employees
- 154
- Programs
- 7
- Drugs
- 2
- Patents
- 9
News & analysis
NovaPharmaNews articles mentioning Tango Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Tango Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.